Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
All storage and handling instructions including the diluent to use, the reconstitution method, and any beyond-use date (BUD) must come exclusively from the trial sponsor's pharmacy manual, the dispensing NHS hospital aseptic unit, or the IMP label supplied with your preparation
Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with biobakery 3
Abstract Obesity is reaching epidemic proportions globally and represents a major cause of comorbidities, mostly related to cardiovascular disease
A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists and behavioral experts at the University of California, Irvine, are raising concerns that treating childhood obesity and type 2 diabetes with weight-loss drugs using glucagon-like peptide-1 receptor agonists (GLP-1RA) may have unintended and adverse consequences for children's health
US$ 23.06
US$ 27.03
US$ 23.40
US$ 24.64
